WNT10A and renal cell carcinoma: Subsequently the clinical association was evaluated by immunohistochemistry and molecular validation was investigated in cell line models Our results showed that WNT10A played a distinct oncogenic role by activating β-catenin-dependent pathway, which may promote RCC carcinogenesis and progression.